A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials Ana MacedoMagí FarréJosep-E. Baños Clinical Trials 10 January 2006 Pages: 161 - 172
Incidence of recurrent venous thromboembolism of patients after termination of treatment with ximelagatran Job HarenbergIngrid JörgChristel Weiss Clinical Trial 14 January 2006 Pages: 173 - 177
Effect of fenofibrate on the level of asymmetric dimethylarginine in individuals with hypertriglyceridemia Tian-Lun YangMei-Fang ChenYuan-Jian Li Clinical Trials 31 January 2006 Pages: 179 - 184
Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients Eleonora L. SwartKlaas P. ZuideveldRobert M. J. Strack van Schijndel Pharmacodynamics 20 January 2006 Pages: 185 - 194
Hydrochlorothiazide efficacy and polymorphisms in ACE, ADD1 and GNB3 in healthy, male volunteers Stefan Viktor VormfeldeDaniel SehrtJürgen Brockmöller Pharmacogenetics 01 February 2006 Pages: 195 - 201
Quantitative prediction of macrolide drug-drug interaction potential from in vitro studies using testosterone as the human cytochrome P4503A substrate Thomas M. PolasekJohn O. Miners Pharmacokinetics and Disposition 17 January 2006 Pages: 203 - 208
Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and quazepam Koh-ichi SugimotoNobutaka ArakiAkio Fujimura Pharmacokinetics and Disposition 17 January 2006 Pages: 209 - 215
Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinide Lauri I. KajosaariTiina JaakkolaJanne T. Backman Pharmacokinetics and Disposition 31 January 2006 Pages: 217 - 223
Hyperforin in St. John’s wort drug interactions Rajanikanth MadabushiBruno FrankVeronika Butterweck Pharmacokinetics and Disposition 14 February 2006 Pages: 225 - 233
Gastro-intestinal problems and concomitant medication in NSAID users: additional findings from a questionnaire-based survey in Italy Maria Chiara SilvaniDomenico MotolaNicola Montanaro Pharmacoepidemiology and Prescription 17 January 2006 Pages: 235 - 241
Influence of HCV or HBV coinfection on adverse drug reactions to antiretroviral drugs in HIV patients The French Network of Pharmacovigilance CentresEmmanuelle GuittonMaryse Lapeyre-Mestre Pharmacoepidemiology and Prescription 17 January 2006 Pages: 243 - 249
